Issue Highlights.

The British Journal of Clinical Pharmacology's February issue highlights several research papers on various topics. One study focuses on a potential treatment for autoimmune diseases using a novel C‐X‐C chemokine receptor 3 antagonist. Another paper examines the absorption, distribution, metabolism, and elimination of a cholesterol 24‐hydroxylase inhibitor for the treatment of seizures. Additionally, the issue includes critical evaluations of evidence from clinical studies, such as the use of oral gonadotrophin releasing hormone antagonists for uterine fibroids and the establishment of a children's Drugs and Therapeutics Committee. The issue also discusses the United Kingdom Prescribing Safety Assessment, which assesses the competence of physicians to prescribe medications. Overall, this issue offers valuable insights for clinical pharmacologists. [Extracted from the article]